Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Bio-Works Technologies | BIOWKS | 15. mai 2024 | 2.73 | -2.15 |
BioArctic B | BIOAB | 15. mai 2024 | 239.00 | +13.70 |
BioGaia B | BIOGB | 15. mai 2024 | 134.50 | +1.36 |
BioInvent International | BINV | 15. mai 2024 | 28.95 | +5.85 |
Biosergen | BIOSGN | 15. mai 2024 | 0.30 | -2.60 |
Biovica International B | BIOVICB | 15. mai 2024 | 1.52 | -1.04 |
Calliditas Therapeutics | CALTX | 15. mai 2024 | 118.50 | -3.42 |
Camurus | CAMX | 15. mai 2024 | 567.00 | +0.89 |
Cantargia | CANTA | 15. mai 2024 | 3.54 | -1.23 |
Cereno Scientific B | CRNOB | 15. mai 2024 | 3.72 | +1.09 |
Chordate Medical Holding | CMH | 15. mai 2024 | 0.05 | -17.55 |
Chosa Oncology AB | CHOSA | 15. mai 2024 | 1.11 | -1.34 |
Cline Scientific B | CLINEB | 15. mai 2024 | 0.13 | -4.69 |
Coegin Pharma | COEGIN | 15. mai 2024 | 3.90 | +0.26 |
Combigene | COMBI | 15. mai 2024 | 3.27 | -4.66 |
Corline Biomedical | CLBIO | 15. mai 2024 | 10.10 | 0.00 |
Cyxone | CYXO | 15. mai 2024 | 0.12 | +9.13 |
DexTech Medical | DEX | 15. mai 2024 | 4.40 | -3.51 |
Diagonal Bio | DIABIO | 15. mai 2024 | 0.03 | -46.80 |
Diamyd Medical B | DMYDB | 15. mai 2024 | 13.18 | +14.61 |
Dicot | DICOT | 15. mai 2024 | 0.26 | +0.20 |
Double Bond Pharmaceutical B | DBPB | 15. mai 2024 | 0.70 | -3.33 |
Ectin Research | ECTINB | 15. mai 2024 | 0.45 | -2.62 |
Egetis Therapeutics | EGTX | 15. mai 2024 | 6.72 | +9.62 |
Elicera Therapeutics | ELIC | 15. mai 2024 | 0.85 | -5.12 |
Ellen | ELN | 15. mai 2024 | 1.44 | +4.35 |
Enorama Pharma | ERMA | 15. mai 2024 | 3.50 | +0.29 |
Enzymatica | ENZY | 15. mai 2024 | 3.20 | -1.54 |
EQL Pharma | EQL | 15. mai 2024 | 43.40 | +8.50 |
Eurocine Vaccines | EUCI | 15. mai 2024 | 0.04 | -5.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.